Try our Advanced Search for more refined results
Life Sciences - October, 2021
335 articles
- FDA Authorizes Pfizer Vaccine For Children Aged 5 To 11
- 10 States Sue Biden Over Federal Contractor Vax Mandate
- 5 Details To Know Before High Court Mulls Texas Abortion Ban
- Ill. Judge Won't Halt COVID-19 Vaccine And Testing Mandates
- US Backs Patients In High Court CVS Disability Bias Case
- Mallinckrodt Votes Disputed On Eve Of Ch. 11 Plan Hearing
- FTC Republicans Blast 'Zombie Vote' On Merger Policy
- Endo, Arnold & Porter Split Amid Opioid Litigation Troubles
- Fed. Circ. Axes Philips Heart Monitor Patent Under Alice
- Orangetheory Branch Hit With Suit Alleging Spam Texts
- Fed. Circ. Backs PTAB Decision Upholding HandyLab Patents
- Takeda Takes Home Some Injunctions In Generic Drug Battle
- Quinn Emanuel Can't Escape Insys Ch. 11 Suit Over Payments
- EU Imposes Safeguards For Illumina-Grail Deal During Review
- Shkreli Can't Take The Stand Remotely At FTC Antitrust Trial
- 'Bully' Priest Engineered Biotech Stock Drop, Jury Told
- Canadian Mining Co. Lied To Drive Up Stock Price, Class Says
- Mylan Loses Bid To Stall Trial Over Neurim's Melatonin Patent
- Fed. Circ. Forecast: USPTO To Face Inventor's Bias Claims
- Investor Sues Gas Co. Over Merger Details With Sinclair Oil
- Ex-Aegerion Rep Not 'Over The Law,' Gets 4 Years For Fraud
- Walgreens, CVS Eye Prescription Data In Tribe's Opioid Row
- Illumina Insider Trading Merits 10-Year Sentence, Feds Say
- Flanax Trademark Case Exposes Circuit Rifts, High Court Told
- Juno Urges Fed. Circ. To Undo 'Mischief' In Wiping $1B IP Win
- Avoro Capital Slams Merck's $11.5B Acceleron Deal
- J&J Unit Escapes Antitrust Suit Over Prostate Cancer Drug
- Freshfields Snags 2 Arnold & Porter Life Sciences Partners
- The Most Active Firms In Public False Claims Cases
- Philip Morris Can't Block Cig Warning Rule Set For Late 2022
- Academics Back Illumina's Grail Buy Against FTC Challenge
- Regeneron Gets PTAB To Review Syringe Patent On 2nd Go
- CBD Retailer, Manufacturer Slip Claims They Stole Cream IP
- 2nd Circ. Voices Support For NY Health Care Worker Vax Rule
- Avadim's Ch. 11 Plan Confirmed Over Release Objections
- 'The Genome Defense' Brings Myriad Battle To Life
- Lawyers Can And Should Commit To Climate Action
- FCA Ruling Guides Insureds On Classifying Restitution Costs
- Giant Eagle Strikes Deal To Leave Ohio Opioid Bellwether
- Allergan, Others Appeal £260M Antitrust Fine Over Drug Prices
- Pharmacy Exec Asks Full 1st Circ. To Toss Meningitis Case
- Copyright Office Floats Expanding Right To Repair Devices
- DeVos Family Gave Theranos $100M 'On The Spot,' Jury Told
- Pharmacy Owner Must Disclose Atty Advice In $1B Fraud Trial
- DOJ Accuses Kaiser Of $1B Medicare Fraud, Fake Diagnoses
- Pharma Co. Beats NJ Whistleblower Suit Over Contract Claim
- Skadden Strives To Tame Flames In Endo's Opioid Imbroglio
- Chicago Workers Ask Ill. Judge To Block COVID Vax Mandates
- Insurer, Surgical Supplier Settle Coverage Fight Over J&J Suit
- Imerys Seeks Ch. 11 Mediator After Plan Process Stalls
- ViSalus Seeks 9th Circ. Reprieve From $925M TCPA Verdict
- 5th Circ. Allows Texas Co.'s E-Cigs To Stay On Market
- FDA Panel Backs Pfizer COVID Vaccine In Kids Aged 5-11
- EpiPen Buyers Can't Appeal Order Yet In Antitrust Case
- Feds Want 6 Years For Aegerion Rep's 'Sophisticated' Fraud
- Church & Dwight Escapes Zicam Cold Remedy False Ad Suit
- WTO Nominee Sees Vaccine IP Waiver Talks As 'Sort Of Stuck'
- Leafly Wins Challenge To Fla.'s Medical Pot Online Order Rule
- Insys Execs Owe $48M For Duping Insurers 'All Day,' Feds Say
- Husch Blackwell Scoops Up Lewis Brisbois Labor Leader
- Clinical Research Biz Medable Lands $2B Valuation In Series D
- Opioid Expert's Addiction Calculations Off Base, Jury Hears
- Biden Admin. Announces Vaccine Rules For Int'l Travelers
- J&J Unit Hit With Motion To Send Ch. 11 To New Jersey
- Nevro Loses 11th-Hour Bid To Delay Boston Scientific IP Trial
- Texas Judge Won't Block State's Delta-8 THC Ban, For Now
- Parties In Zantac MDL Propose Path To 2023 Bellwether Trials
- NYPD Union Sues Over 'Draconian' COVID Vaccine Mandate
- Pharmacies' Mistrial Bid Shot Down In Opioid Bellwether
- FTC Formally Reinstitutes 'Prior Approval' In Merger Deals
- St. Jude Medical Wins Atty Fees In Catheter Method IP Suit
- Insurance Coverage Vet Joins Miller Nash Cannabis Team
- Parsing Boeing Decision In Light Of ESG, Caremark Trends
- Confronting Origination Credit: Why GCs Need To Speak Up
- What Evolution Of Public Nuisance Claims Means For Cos.
- CVS Says Ex-Worker Openly Broke Nonsolicitation Agreement
- Purdue Opposes Requests To Delay Ch. 11 Plan For Appeals
- NJ High Court Takes On Nix Of $83M J&J, Bard Mesh Verdicts
- EU Raids Animal Pharma Co. In Probe Of Possible Cartel
- J&J Talc Suits Can Proceed For Now Despite Ch. 11 Filing
- High Court At High Speed: Abortion Cases' Pace Stirs Interest
- Ex-Pfizer Scientist Rips Report Holmes Sent To Walgreens
- Ranbaxy Argues It Can't Monopolize Drugs It Never Sold
- 2nd Circ. Says No To Third Shot At Vitamin C Exporters
- Virginia Judge Ships Suit Over AbbVie's Humira To Illinois
- Pharma Co. Wants €140M AOP Orphan Award Suit Tossed
- 4 Firms Rep $193M In Biotech, Life Sciences-Focused IPOs
- What Blockchain Means For The Future Of US Health Care
- Chicago Workers Sue Governor, City Over Vaccine Mandates
- Ex-Insys CEO Gets 8 Months Shaved Off Prison Term
- White & Case Program Aims To Draw Students To IP Law
- Insurer Says Exclusions Apply To Pharma Co.'s BIPA Suit
- 3 Firms Rep 23andMe's $400M Buy Of Telehealth Biz Lemonaid
- Beltway Moves: Ex-Trump DOJ Official, Covington, O'Melveny
- Burns & Levinson Snags Patent Ace From Dinsmore & Shohl
- Texas Firm Wants Pharma Co. To Pay $113K Arbitration Award
- Justices Will Hear Challenges To Texas' 6-Week Abortion Law
- Goodwin Adds Life Sciences Partner From Hogan Lovells
- UK Litigation Roundup: Here's What You Missed In London
- CDC Backs COVID-19 Booster Shots For All 3 Vaccines
- IP Forecast: Google Lyrics Battle To Play Out At 2nd Circ.
- 5 Accused Of Laundering Funds From Venezuela Bribery Plot
- Del. Justices Uphold $275M AstraZeneca Drug Trial Debt Toss
- Fla. Official Blasts New Pot License Rules As Discriminatory
- Hill-Rom, Baxter Get FTC Warning Letters For $12.4B Deal
- Texas Rips DOJ's 'Extraordinary' Abortion Suit At High Court
- Apotex Backs Teva's En Banc Bid In Skinny Label Fight
- What To Watch In Telehealth Enforcement
- Ex-Ventilator Exec Must Face Poaching Suit, 1st Circ. Told
- Venue Change On Table For J&J Talc Unit's Ch. 11
- Feds Oppose Service Members' Anonymity In Vaccine Suit
- McKesson Nears Win On Some Securities Fraud Claims
- Atty Accused Of 'Heinous Fraud' With Privileged Insys Docs
- Woman Keeps $1.2M Med Mal Verdict Over Spinal Surgery
- 'Mix-And-Match' COVID-19 Boosters Win FDA Clearance
- Holmes Was Coached By Marketing Firms, Jury Told
- Bayer Will Have To Face Investor Suit Over Roundup Litigation
- Eli Lilly Must Pay Royalties In Diabetes Drug Row, Judge Says
- J&J, Ethicon Beat Pa. Woman's Untimely Hernia Mesh Suit
- Mylan Asks Fed. Circ. To Flip PTAB's Ruling On Merck Patent
- Rutgers Aims To Unmask Students Behind COVID Vaccine Suit
- Chancery Won't Delay CytoDyn Board Meeting
- 8th Circ. Sends Civilians' 3M Earplug Suits To State Court
- Atrium Wins Quick Verdict In Chicago In 1st Hernia Mesh Trial
- Purdue Asks To Pay Ch. 11 Costs Of Government Committees
- 3 Firms Shape $430M Carlyle-Led Pharma Analytics Co. Boost
- Judge Will Rethink SEC's Partial Win Against Ex-Biotech CEO
- 1st Circ. Clears Vax Mandate For Maine Health Care Workers
- How To Overcome Risks Of Virtual Expert Testimony
- Financial Planning Tips For Retiring Law Firm Partners
- 4 Practical Pointers For Litigating A Design Patent Case
- Teva Fears 'Incredibly Damaging' Parody Videos In Opioid Trial
- Holmes OK'd Testing Claims Over Atty's Concerns, Jury Told
- Shkreli Cites Rehab Too Late To Delay FTC Antitrust Trial
- Christian Employers Target Trans Health Coverage Rules
- AGs Want Facebook's Logs On Vax 'Disinfo Dozen'
- Taiwanese Pharma Co. Fights AOP Orphan's Sanctions Bid
- Teva Fights Eli Lilly's Bid To Toss Migraine Drug IP Case
- Preparing Remote Deposition Defenses For Corporate Entities
- Cleary-Led Chipmaker Leads Four IPO Launches Totaling $4B
- Rutgers Students Want To Hide Names In COVID Vaccine Suit
- How Food Safety Ruling Supports FDA Framework
- Del. Judge Puts Off Ruling On HHS Discount Pharmacy Fight
- Md. Judge Refuses Sanctions In Superfund Cleanup Case
- J&J's Bankrupt Unit Says Ch. 11 Stay Extends To Parent Co.
- Generic-Drug Group Wants Justices To Intervene Against FTC
- Tech, Life Sciences Spar Over Eligibility In USPTO Comments
- Texas Has 'Nullified' Abortion Right, DOJ Tells Justices
- FDA Clears 1st Drug Interchangeable With AbbVie's Humira
- FTC Says Shkreli Has No Good Reason To Delay Antitrust Trial
- Walmart Blasts Ohio Counties' Sanctions Bid In Opioid Trial
- Fed. Circ. Won't Eye Decision Upholding Teva Cancer Drug IP
- Rejected CytoDyn Slate Seeks Injunction After Del. Ruling
- Strategies To Counter Broad Approach To IPR Estoppel
- Amarin Investors Want 3rd Circ. To Revive Heart Drug Suit
- Why Law Schools Should Require Justice Reform Curriculum
- Opioid Inquiry Faults Arnold & Porter But Rejects Some Relief
- Endo Investors Ink $63M Deal In Generics Stock Inflation Suit
- Teligent's Distributors Balk At Customer Risks In Ch. 11
- Most Cancer Claims Survive In Suit Over Weight Loss Drug
- Theranos' Test Demo Hid Failures From Investors, Jury Told
- Zydus Infringed AstraZeneca's Diabetes Drug IP, Judge Rules
- Skin Care Co. Ordered To Pay $2.3M For Copied Packaging
- NY Counties Sound Alarm Over Doctor As Opioid Trial Witness
- Brand Battles: DC Comics Faces TM Fight Over 'The Flash'
- Polo Star Wants Court To Block Sales Of Cloned Horse
- UK Litigation Roundup: Here's What You Missed In London
- Compliance Tips For Marketing Health Benefits In Alcohol
- Resistance To J&J's Bankruptcy Gambit May Be Futile
- DOJ Unveils 3 Settlements, $20M Neuro-Stimulator Fraud Suit
- Nimbus, Bristol-Myers Can't Sell Psoriasis Drug Amid Dispute
- Latham-Led Orthopedics Firm Leads 2 IPOs Totaling $165M
- UK Watchdog Probing Thermo Fisher's $21B PPD Deal
- Nelson Mullins Adds 2 Morris Manning Health Care Attys
- Health Hires: Orrick, Sheppard Mullin
- Goodwin Snags Another Litigator From Manatt In SoCal
- Convicted Insys Founder Seeks Deep Cut To Restitution
- Mallinckrodt Ch.11 Plan Under Fire From Multiple Angles
- FDA Panel Backs J&J COVID Booster For Ages 18 And Up
- DuPont, Others Must Face NJ Water Co.'s Pollution Suit
- Boehringer Loses Bad Faith Claim In Diabetes Drug Deal Suit
- Pharmacies Slam Cherokee Bid To Remand Opioid Claims
- CR Bard Can't Escape Texas Man's Heart Filter Suit
- 5th Circ. Says Texas Abortion Law Can Be Enforced For Now
- Holmes Prayed As WSJ Reporter Raised Doubts, Jury Told
- Shkreli Wants FTC's Monopolization Trial Pushed Back
- Insurer Says Lab Charged Up To $979 Per COVID-19 Test
- Dental Co. To Pay $63M To End Investors' Price-Fixing Suit
- Lawmakers Say Moderna Deal May Let Gov't Share Vax Recipe
- Texas Judge Wants Unions' Input On United Vaccine Mandate
- Fenwick-Led Software Company Among 3 IPOs Raising $1.2B
- Johnson & Johnson Puts Talc Spinoff Into Ch. 11
- College Of NJ Students Can't Halt COVID-19 Vaccine Mandate
- 9th Circ. Chromium Ruling May Expand Water System Liability
- WTO Makes Some Progress On COVID IP Waiver Talks
- Purdue Ch. 11 Plan Challenges Won't Hit 2nd Circ. Right Away
- McDermott Continues Energy Hiring With Baker McKenzie Atty
- Chancery Rejects CytoDyn Dissidents' Late Board Slate Bid
- Barnes & Thornburg Snags IP Partner From Womble Bond
- NYC Teacher Vax Rule Seems Likely To Pass 2nd Circ. Test
- Pharma Co. Teligent Opens Ch. 11 In Del. With $130M Debt
- Ex-Walgreens Exec Told Holmes 'Haters Are Everywhere'
- Texas Judge Doubts He Can Stop United's Vaccine Mandate
- Counsel In $1.8B Biotech Sale Suit Urged To Work Together
- Teamsters Can't Arbitrate Mandatory COVID-19 Vaccine Policy
- Investor Says Biotech Co. Hid Issues Leading To Delays
- Louisiana Can't Wade Into FTC's Settled Provigil Case
- Bayer Tells High Court To Curb Flanax Fight Again
- Judge Tosses 16K Talc Claimant Votes In Imerys Ch. 11
- Del. Justices Probe Unclear Terms In AstraZeneca Merger Pact
- Pain Doc Tells NY Jury Consulting Work Didn't Hurt Patients
- EPA Takes First Step Toward Ethylene Oxide Reporting
- Quinn Emanuel Loses Latest Partner To White & Case
- Rhode Island Balks At Mallinckrodt Ch. 11's CEO Release
- California Sued Over Vaccination Site 'Bubble Zone' Law
- Philips Hit With $200M Suit By CPAP Cleaner Co. Over Recall
- Girardi Scandal Provides Important Ethics Lessons
- How Social Media, Mass Torts Affect Adverse Event Reports
- Allergan Inks $30M Deal With Restasis Buyers In Antitrust Suit
- NORML Warns Against Unregulated Delta-8 Products
- Quarles & Brady Nabs Veteran SDNY Assistant Atty
- Pfizer Gives Gov't More Time To Study $2.3B Trillium Deal
- Latham Helped Vet Theranos Deal, Ex-Safeway CEO Says
- Fed. Circ. Told Minerva Still Can't Challenge Hologic Patent
- Sanofi Whistleblowers Were Legitimately Fired, NJ Court Told
- Janssen Wins Push To Arbitrate Zytiga Generic Delay Suit
- 2 Firms Guide PharmaCann's Colo. Pot Co. Acquisition
- FDA Approves 3 RJ Reynolds Vaping Products
- Embracing ESG: Jabil GC Talks Compliance Preparation
- Home Health Cos. Ink $8.5M Deal In Medicare Row, Feds Say
- Insurer Accuses Jazz Pharma Of 'Grotesque' Antitrust Scheme
- Predicting Fed. Circ. Rule 36 Affirmances In Patent Cases
- NYC Vaccine Orders Survive Scrutiny In 2 Court Rulings
- Purdue Ch. 11 Appeals To Be Heard Before Plan Effective Date
- Philips Sleep Apnea Device Suits Sent To Pa. Federal Court
- Foley & Lardner Opens Salt Lake City Office With IP Team
- Hot Dog Restaurateur Leads 5 IPO Launches Exceeding $1B
- Chubb Unit Must Cover $10M Of Drugmaker's DOJ Settlement
- Bankruptcy Venue Reform Bill Needs Amending
- Top Court Won't Review Toss Of $1M Abbott Age Bias Award
- Pfizer Sold Carcinogen-Tainted Chantix, Buyers Claim
- Pot Biz Residency Rules To Face Biggest Challenge Yet
- McKesson Wins Class Decertification In 'Junk Fax' Fight
- NY Judge Doubts Challenge To Vax Mandate But Grills City
- FTC's Chopra Knocks Agency's Merger Remedies Study
- GOP Sen. Says Waiving COVID Copyrights Also 'Devastating'
- Health Hires: Manatt, Holland & Knight
- 9th Circ. Affirms Siemens Win In False Ads Appeal
- JPML Sends J&J Sunscreen Carcinogen Suits To Florida
- 3 Ways CLOs Can Drive ESG Efforts
- China Tariff Relief Is Back, And So Is Importers' Angst
- Why Congress Should Pass Whistleblower Protection Law
- New Trial Sought In CR Bard Hernia Mesh Bellwether
- 2 Cases Will Help Shape Opioid Litigation Insurance Coverage
- Green Groups Blast Exxon's 'Tortured' Appeal Of $14M Award
- NJ Medical Device Co. Must Face Class Claims Over IPO
- Canadian Creditors Seek Direct Appeal Of Purdue Ch. 11 Plan
- FDA 'Vaccine' Label Not Last Word On Mandate, Court Told
- UK Litigation Roundup: Here's What You Missed In London
- Taxation With Representation: Shearman, Latham, Boggs
- Teva Gets Bayer's Cancer Drug Patent Invalidated In UK
- Hearing Aid Co. Sued Over DOJ Insurance Claims Probe
- IP Forecast: SAP To Spar Over Trade Secrets, Patents
- Moderna Faces Skeptical Fed. Circ. On Threat To COVID Shot
- United Moves To Trim COVID-19 Vax Mandate Suit
- How Law Firms Can Rethink Offices In A Post-Pandemic World
- College's Unvaccinated Athletes Can Play, 6th Circ. Says
- Teva Says GSK Skinny Label Win Will Have 'Seismic' Impact
- HHS Accused Of Overstepping Role In Drug Discount Program
- Doc Can Subpoena Yelp User Info In Botox Defamation Suit
- NJ Panel Revives Aetna's Fraud Claims Over Lab's Crimes
- MabVax Brass Slip Suit By Alleged Pump-And-Dump Investor
- Drug Cos. Can't Nix Monitoring Class In Zantac MDL
- Ex-Safeway CEO Says Theranos Didn't Deliver On $55M Deal
- Walgreens, Purdue 'Colluded' To Spread Opioids, Jury Hears
- Court Sides With Rival In AbbVie's Trade Secrets Suit
- Mallinckrodt Facing $93M Drug Royalty Claim In Ch. 11
- Synthego Says It Doesn't Infringe Agilent CRISPR Patents
- A Cell For A Stall: Jailed Exec Wants Out To Run Horse Farm
- Inyx Fraudster Seeks New Trial Over Jury Instructions 'Error'
- SC AG Says Congress Likely Didn't Legalize Delta-8 THC
- PTAB Revision Bill Offers US Makers Much-Needed Protection
- DOL Urges Revival Of Hartford ERISA Suit At 2nd Circ.
- Protecting Attorney-Client Privilege In Human Rights Audits
- Boston Scientific Boosts Heart Biz With $1.75B Baylis Buy
- Ex-Theranos Lab Chief Says Ebola Rumor Was 'Final Straw'
- CVS, Walmart Opioid Trial Defense Hazy On Pharmacists' Role
- King & Spalding Nabs Dechert International Arbitration Atty
- Fed. Circ. Upends St. Jude's PTAB Win In Heart Valve IP Row
- NY's New Pot Regulators Expand Access To Medical Patients
- AOP Orphan Seeks Sanctions On Taiwanese Pharma Co.
- Wash. Tribal Corp. Says Stanford Used Its IP For Drug Patent
- Perrigo To Pay $31.9M To Settle Tax Suit With Fla. Groups
- USTR May Revive Tariff Breaks On Over 500 Chinese Goods
- Senate Bill Targets Generic Drug Delay Tactic
- Will Kanter Transform Cartel Enforcement?
- Amplify Faces Putative Class Action For 'Catastrophic' Spill
- 3rd Circ. Urged To Nix Future Claims Rep From Imerys Ch. 11
- NJ College Blasts Claim COVID-19 Shots Are Not Vaccines
- Pharmacies' Opioid Screening 'Totally Ineffective,' Jury Hears
- High Court Urged To Take Up Monsanto Roundup Appeal
- Thermo Fisher Sued Over Use Of Henrietta Lacks' Cells
- Justices Duck Jurisdiction Issue On Cases Sent To Fed. Court
- DOL Contractor Watchdog Unveils $3.3M Worth Of Bias Deals
- 9th Circ. Clarifies Timely Removal Of Suits In Boeing Case
- Fed. Circ. Says Art Tool Can't Block Lip Implant Design Patent
- Manufacturers Face Evolving COVID-19 Legal Challenges
- Drugmakers In Zantac MDL Try To Trim Claims
- Justices Turn Away IP Cases Over MS Drug, Costly Prior Art
- J&J Unit Must Face Claims Pelvic Mesh Was Defective
- Illinois Hospital Tries To Escape Antitrust Suit
- Embracing ESG: Baker Hughes CLO Talks Sustainability Team
- Express Scripts Says EpiPen RICO Claims Are Time-Barred
- Commerce Puts Export Curbs On Gene-Editing Software
- Lead Compound Analysis Is Making Inroads At USPTO
- Coding Platform Leads 6 IPO Launches That Could Top $1.8B
- Justices Won't Hear Trade Groups' NY Opioid Tax Challenge
- Counties Say Opioid Trial Can Redress 'Great Stress' Of Crisis
- Sotomayor Rejects NYC Teachers' Bid To Block Vax Mandate
- Ex-Theranos Lab Chief Testifies That Balwani Wasn't Qualified
- Supreme Court's Return Could Deliver Conservative Windfall
- More Than Fintiv: What To Know About The PTAB Revision Bill
- Judge Says Pfizer Heart Drug Copay Program Is A Kickback
- Judge To Reconsider Partial SEC Win Against Ex-Biotech Exec
- Pro Say: A Supreme Court Term Packed With Landmark Cases
- Generic Drug Makers To Pay $447M Over Fixed Prices
- 3 IPOs Across Far-Flung Industries Raise $823M Combined
- Merck Accuses Bayer Of Ducking Product Liability Claims
- Up Next At High Court: State Water Rights, CIA Black Sites
- What Mainstreaming Of Litigation Finance Means For Industry
- Fla. Firm Wins $1M Lien After Client Reneges On Settlement
- Taxation With Representation: Ropes, Kirkland, Latham
- 3rd Circ. Preview: Insurance Drives Ch. 11, Antitrust Cases
- UK Litigation Roundup: Here's What You Missed In London
- Kavanaugh Tests Positive For COVID, Has No Symptoms